GlassScriptPhysician profile
Jennifer Stacy
NPI 1568962843
$1,102.74
in general payments reported to CMS, 2019-2025
12 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.82 · 2020: $38.04 · 2021: $256 · 2022: $301 · 2023: $232 · 2024: $91.34 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $501.30 | 2021-2023 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $176.07 | 2020-2025 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $92.21 | 2021-2025 | Relistor |
| Arbor Pharmaceuticals, INC. | $59.06 | 2021-2022 | |
| Nevro Corp. | $57.65 | 2019-2024 | Senza |
| Fidia Pharma USA INC. | $35.99 | 2023-2024 | Triluron, Hymovis, Hyalgan |
| Redhill Biopharma INC. | $35.46 | 2021-2022 | |
| Globus Medical, INC. | $34.96 | 2025 | Omnia |
| Boston Scientific Corporation | $34.65 | 2025 | Wavewriter Alpha Prime 16 |
| Biodelivery Sciences International, INC. | $26.97 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $25.28 | 2023 | Exparel, Iovera, Zilretta |
| Alnylam Pharmaceuticals INC. | $23.14 | 2024 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Stacy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.